Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Paediatr Drugs. 2018 Oct;20(5):483–495. doi: 10.1007/s40272-018-0305-1

Figure 2.

Figure 2.

The difference between an individual’s parameter and the population value (ETA) for clearance (ETA_CL) vs. CYP2C19 genotype (A), clearance (ETA_CL) vs. age (B), volume of distribution (ETA_V) vs. waist:hip ratio (C) and clearance (ETA_CL) vs. total body weight (D) in the base pantoprazole pharmacokinetic model.